医学
间变性淋巴瘤激酶
恶性肿瘤
病理
上皮样细胞
揭穿
肉瘤
肺癌
癌症
免疫组织化学
内科学
恶性胸腔积液
卵巢癌
作者
Daniel E. Sarmiento,Jessica A. Clevenger,Gregory A. Masters,Thomas Bauer,Brian Nam
出处
期刊:PubMed
日期:2015-10-01
卷期号:7 (10): E513-6
被引量:19
标识
DOI:10.3978/j.issn.2072-1439.2015.10.55
摘要
Inflammatory myofibroblastic tumor (IMT) of the lung is a rare malignancy with few cases reported in the literature. Histologically, it is composed by spindle cells and an infiltrate of inflammatory cells. Children and young, non-smoking adults constitute the majority of cases, the clinical behavior ranges from a benign entity to a malignant process with rapid recurrence and metastatic progression. We present a case of epithelioid inflammatory myofibroblastic sarcoma (EIMS) of the pleura, a malignant variant of IMT, which was initially treated with debulking surgical resection followed by systemic chemotherapy. The tumor was found to have an anaplastic lymphoma kinase (ALK) gene rearrangement. An ALK directed tyrosine kinase inhibitor was used with an impressive response, the patient remains in remission nearly 1 year after presentation. The pathogenesis, pathologic findings, clinical behavior and imaging of pulmonary EIMS are discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI